📰 Pharmaceutical Development News
Page 8 - Pharmaceutical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmaceutical Development. Real-time updates on events, politics, business and more.
August 10, 2022
Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET Corporate Highlights Celebrated 10th anniversary as a life...
August 3, 2022
Biktarvy Sales Increased 28% Year-Over-Year to $2.6 billionOncology Sales Increased 71% Year-Over-Year to $527 millionFOSTER CITY, Calif.--(BUSINESS WIRE)--#Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.“This was a very strong quarter for Gile...
August 1, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
July 23, 2022
BALD HEAD ISLAND, N.C. (AP) — About 3 miles off the coast of Southeastern North...
July 20, 2022
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
July 17, 2022
The Democratic Labour Party (DLP) is pushing “new politics” in Barbados and will soon be engaging the public on a variety of issues, says president Dr Ronnie Yearwood. During a media briefing yesterday at the DLP’s George Street, Belleville, St Michael headquarters, he said they did not believe in “top-down” governance. “Political parties are often seen as top-down institutions, where the policy comes from the leader and everybody is expected …
July 15, 2022
Bald Head Island Academy, a private K-8 institution, will be the first school in the islands history.
July 8, 2022
More self-administered healthcare requires innovative packages tailored for patients/caregivers in a design-centric approach that also show care for the planet.
June 21, 2022
With two knighthoods in the last month, here EPR discusses five developments in the drug development community’s C-suite.
June 5, 2022
Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing